An amendment to the National Defense Authorization Act (NDAA) introduced to Congress would require the creation of a reporting system for adverse events that may be associated with dietary supplements use in the military. Trade group CRN is pushing back,...
A study on professional athletes competing in Olympic sports has found that the players think they know more about supplements and nutrition than they actually do. The researchers called for more education and monitoring by coaches to inform correct supplement...
Editor's Spotlight: Notes from Nutrition 2019 in Baltimore, June 8-11
Is there a role for cannabis and its derivatives to play in our food system, perhaps as part of a healthy, well-balanced diet? Scientists explored the question at the recent Nutrition 2019 conference in Baltimore.
More than 60% of probiotic supplements in the US may lack sufficient information on their labels to allow consumers to make informed decisions, according to a new study led by Dr Dan Merenstein from Georgetown University Medical Center.
Early returns from the FDA meeting on CBD regulation give a glimpse of the complexity of the regulatory questions, which might stretch the timeline for a new legal framework to extent beyond which many in the industry would find acceptable.
Two nutrition scientists who became angry about the number of social media celebs with more influence than health experts have created a network to empower their colleagues to have a real impact on the future of nutrition.
A new force is shaping the dietary supplement market, one that operates largely outside of normal industry channels. The growth of the online sales channel, and brands that operate exclusively in that space, is an increasingly powerful force.
What’s the typical profile of an energy drink consumer in the US, and how much are they drinking? Researchers from the Harvard T.H. Chan School of Public Health analyzed data from a national health survey to get some answers.
The Center for Science in the Public Interest (CSPI) sent a letter to the FDA yesterday, asking the agency to take enforcement action against 15 companies selling products as dietary supplements to help smokers quit.
The recent slew of warning letters on DMHA and phenibut signals a new scrutiny on the part of FDA of ingredient status without reference to other issues, says an attorney with a long history in the field.
The US Food and Drug Administration issued 11 warning letters yesterday to companies that have non NDI ingredients in their products. Eight of the warning letters concerned DMHA, with the other three concerned phenibut.